Thesis Abstract

Abstract
The treatment of cancer has advanced significantly over the years, with a shift towards targeted therapies that aim to deliver drugs specifically to cancer cells while minimizing damage to healthy tissues. In this context, the development and evaluation of novel drug delivery systems play a crucial role in enhancing the effectiveness and safety of cancer therapy. This thesis focuses on investigating and assessing innovative drug delivery systems for targeted cancer therapy. The introduction provides a comprehensive overview of the current landscape of cancer treatment, highlighting the limitations of traditional chemotherapy and the potential benefits of targeted drug delivery systems. The background of the study delves into the principles of targeted therapy and the importance of developing drug delivery systems that can overcome biological barriers and improve drug efficacy. The problem statement identifies the challenges associated with existing drug delivery systems, such as poor specificity, limited bioavailability, and systemic toxicity. The objectives of the study are outlined to address these challenges by designing and evaluating novel drug delivery systems tailored for targeted cancer therapy. The limitations of the study are also discussed, including potential constraints in resources and time. The scope of the study encompasses the design, development, and evaluation of various drug delivery systems, including nanoparticles, liposomes, micelles, and other nano-carriers. The significance of the study lies in its potential to contribute to the advancement of cancer therapy by enhancing drug delivery efficiency, reducing side effects, and improving patient outcomes. The structure of the thesis is presented to guide the reader through the different chapters, including the literature review, research methodology, discussion of findings, and conclusion. Definitions of key terms are provided to ensure clarity and understanding of the concepts discussed throughout the thesis. The literature review chapter examines existing research and developments in the field of drug delivery systems for cancer therapy. Ten key areas are explored, including the principles of targeted drug delivery, nanotechnology in cancer treatment, and the challenges of drug resistance. The research methodology chapter outlines the experimental design, materials, and methods used to develop and evaluate novel drug delivery systems. Eight components are detailed, covering aspects such as formulation techniques, characterization methods, and in vitro and in vivo studies. The discussion of findings chapter critically analyzes the results obtained from the evaluation of the novel drug delivery systems. The efficacy, safety, and potential applications of these systems are discussed in depth, highlighting their strengths and limitations. The conclusion and summary chapter provide a comprehensive overview of the key findings, implications, and future directions of the study. The contributions of this research to the field of targeted cancer therapy are emphasized, along with recommendations for further research and development. In conclusion, this thesis contributes to the growing body of knowledge on drug delivery systems for targeted cancer therapy. By developing and evaluating novel approaches to drug delivery, this research aims to improve the effectiveness and safety of cancer treatment, ultimately benefiting patients and advancing the field of oncology.

Thesis Overview

The project titled "Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy" aims to address the pressing need for more effective and targeted treatment options for cancer patients. Cancer remains one of the leading causes of morbidity and mortality worldwide, and traditional cancer therapies such as chemotherapy and radiation often lack specificity, leading to significant side effects and limited efficacy. The development of novel drug delivery systems offers a promising avenue to improve the effectiveness of cancer treatment while minimizing adverse effects on healthy tissues. This research project will focus on the design, development, and evaluation of innovative drug delivery systems tailored specifically for targeted cancer therapy. By leveraging advancements in nanotechnology, biomaterials, and pharmaceutical sciences, the project aims to overcome the limitations of current cancer treatment modalities and enhance the precision and efficiency of drug delivery to cancer cells. The research will begin with a comprehensive literature review to establish the current landscape of drug delivery systems in cancer therapy, highlighting the challenges and opportunities in the field. Drawing upon this knowledge, the project will then proceed to the design and synthesis of novel drug delivery platforms, taking into consideration factors such as biocompatibility, stability, and specificity to cancer cells. The evaluation of these novel drug delivery systems will involve in vitro and in vivo studies to assess their efficacy in delivering therapeutic agents to cancer cells, as well as their safety profile and pharmacokinetic properties. By employing advanced imaging techniques and molecular biology assays, the project aims to elucidate the mechanisms of action of these new drug delivery systems and their impact on cancer cell growth and survival. The findings of this research will contribute valuable insights to the field of targeted cancer therapy, potentially leading to the development of more effective and personalized treatment strategies for cancer patients. By enhancing the precision and efficiency of drug delivery to cancer cells, the project has the potential to improve patient outcomes, reduce treatment-related side effects, and pave the way for the translation of these innovative drug delivery systems into clinical practice.